877 related articles for article (PubMed ID: 25956608)
1. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
Armada L; Marotta Pdos S; Pires FR; Siqueira JF
J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis.
Giannopoulou C; Martinelli-Klay CP; Lombardi T
Acta Odontol Scand; 2012 Dec; 70(6):629-34. PubMed ID: 22214279
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts.
de Moraes M; de Lucena HF; de Azevedo PR; Queiroz LM; Costa Ade L
Arch Oral Biol; 2011 Nov; 56(11):1256-63. PubMed ID: 21683340
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of RANK, RANKL, OPG, VEGF, and vWF in radicular and dentigerous cysts.
de Moraes M; de Matos FR; de Souza LB; de Almeida Freitas R; de Lisboa Lopes Costa A
J Oral Pathol Med; 2013 Jul; 42(6):468-73. PubMed ID: 23278112
[TBL] [Abstract][Full Text] [Related]
5. The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas.
Tekkesin MS; Mutlu S; Olgac V
Head Neck Pathol; 2011 Sep; 5(3):248-53. PubMed ID: 21643971
[TBL] [Abstract][Full Text] [Related]
6. Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas.
Menezes R; Bramante CM; da Silva Paiva KB; Letra A; Carneiro E; Fernando Zambuzzi W; Granjeiro JM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):404-9. PubMed ID: 16920551
[TBL] [Abstract][Full Text] [Related]
7. Expression of receptor activator of nuclear factor kappa-B as a poor prognostic marker in breast cancer.
Park HS; Lee A; Chae BJ; Bae JS; Song BJ; Jung SS
J Surg Oncol; 2014 Dec; 110(7):807-12. PubMed ID: 25111682
[TBL] [Abstract][Full Text] [Related]
8. Expression of Toll-like receptors 2 and 4 and the OPG-RANKL-RANK system in inflammatory external root resorption and external cervical resorption.
Lin YP; Love RM; Friedlander LT; Shang HF; Pai MH
Int Endod J; 2013 Oct; 46(10):971-81. PubMed ID: 23521017
[TBL] [Abstract][Full Text] [Related]
9. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
Liu W; Zhang X
Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286
[TBL] [Abstract][Full Text] [Related]
10. Receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in chronic apical periodontitis: possible association with inflammatory cells.
Fan R; Sun B; Zhang CF; Lü YL; Xuan W; Wang QQ; Yin XZ
Chin Med J (Engl); 2011 Jul; 124(14):2162-6. PubMed ID: 21933620
[TBL] [Abstract][Full Text] [Related]
11. RANK, RANKL, and OPG in recurrent solid/multicystic ameloblastoma: their distribution patterns and biologic significance.
Siar CH; Tsujigiwa H; Ishak I; Hussin NM; Nagatsuka H; Ng KH
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):83-91. PubMed ID: 25446507
[TBL] [Abstract][Full Text] [Related]
12. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats.
Lu J; Liu F; Liu D; Du H; Hao J; Yang X; Cui W
Exp Biol Med (Maywood); 2016 Jun; 241(11):1237-49. PubMed ID: 26908571
[TBL] [Abstract][Full Text] [Related]
13. [The expression and significance of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in periapical cyst and periapical granuloma].
Zhang M; Yu Y; Miao Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2012 Aug; 30(4):360-3. PubMed ID: 22934488
[TBL] [Abstract][Full Text] [Related]
14. Expression of the RANK/RANKL/OPG system in the human intervertebral disc: implication for the pathogenesis of intervertebral disc degeneration.
Sano T; Akeda K; Yamada J; Takegami N; Sudo T; Sudo A
BMC Musculoskelet Disord; 2019 May; 20(1):225. PubMed ID: 31101043
[TBL] [Abstract][Full Text] [Related]
15. RANK/RANKL/OPG system in the intervertebral disc.
Takegami N; Akeda K; Yamada J; Sano T; Murata K; Huang J; Masuda K; Sudo A
Arthritis Res Ther; 2017 Jun; 19(1):121. PubMed ID: 28576140
[TBL] [Abstract][Full Text] [Related]
16. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.
Owen S; Ye L; Sanders AJ; Mason MD; Jiang WG
Anticancer Res; 2013 Jan; 33(1):199-206. PubMed ID: 23267146
[TBL] [Abstract][Full Text] [Related]
17. [The OPG/RANKL/RANK system and bone resorptive disease].
Liu JZ; Ji ZL; Chen SM
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):655-60. PubMed ID: 15971575
[TBL] [Abstract][Full Text] [Related]
18. [Expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in chronic apical periodontitis].
Fan R; Zhang CF; Gao Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 40(1):39-42. PubMed ID: 18278135
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis.
Xu F; Dong Y; Huang X; Chen P; Guo F; Chen A; Huang S
Mol Med Rep; 2016 Sep; 14(3):2289-96. PubMed ID: 27430581
[TBL] [Abstract][Full Text] [Related]
20. Immune-Inflammatory Cell Profile and Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin Expression in Persistent Apical Periodontitis after Root Canal Retreatment Failure.
Estrela C; Decurcio Dde A; Silva JA; Batista AC; de Souza Lima NC; de Freitas Silva BS; de Souza JA; Souza Costa CA
J Endod; 2016 Mar; 42(3):439-46. PubMed ID: 26806398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]